Tereza Cervenka, MD

Dr. Cervenka is a Minnesota native interested in general pulmonology, critical care, and sleep medicine. Dr. Cervenka enjoys involvement with University of Minnesota medical students and physicians in training. Personal interests include raising two boys, swimming, and reading.

Education

• 1987-1991, BA Film, St. Olaf College, Northfield, Minnesota
• 1996-2000, MD, University of Minnesota Medical School
• 2000-2003, Internal Medicine Residency, University of Minnesota
• 2003-2007, Pulmonary/Critical Care Fellowship, University of Minnesota

Board Certification

Pulmonary Medicine - 2009

Publications

Rocchini AP, Wilson RF, Marker P, Cervenka T. Metabolic and hemodynamic effects of graded intracoronary insulin infusion in normal and fat anesthetized dogs: a preliminary study. Hypertension; 27:354-359, 1996.

Rocchini AP, Marker P, Cervenka T. Time course of insulin resistance associated with feeding dogs a high-fat diet. American Journal of Physiology; 272: E147-54, 1997.

Miller JS, Cervenka T, Lund J, Okazaki IJ, Moss J. Purine metabolites suppress proliferation of human NK cells through a lineage-specific purine receptor. Journal of Immunology; 162: 7376-7382, 1999.

Zhang Y, Wroblewski M, Hertz M, Wendt C, Cervenka T, Nelsestuen G. Analysis of chronic lung transplant rejection by MALDI-TOF profiles of bronchoalveolar lavage fluid. Proteomics; 6(3):1001-1010, 2006.

Abstracts

Cervenka T, Nelsestuen G, Martinez M, Hertz M, Wendt C. Human Neutrophil Defensins 1-3: A biomarker of chronic lung allograft rejection. Oral presentation of abstract, Am J  Transplant  2004; S8(4):273.

Wendt C, Cervenka T, Zhang Y, Hertz M, Nelsestuen G. Biomarkers of chronic lung allograft rejection: A proteomic approach. Poster presentation of abstract, American Thoracic Society, 5/2005.

Cervenka T, Nelsestuen G. Savik K. Hertz M. Wendt C. Clara cell secretory protein is a biomarker for chronic lung allograft rejection due to early targeting of clara cells. Oral presentation of abstract, American Thoracic Society 5/2006.

Cervenka T, Nelsestuen G, Savik K. Hertz M. Wendt C. Human neutrophil defensins 1-3 predict the diagnosis of bronchiolitis obliterans syndrome in a prospective analysis of lung transplant patients. Oral presentation of abstract, American Thoracic Society 5/2006.